Article info

Download PDFPDF
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial
  1. Address correspondence and reprint requests to Antonio González-Martín, MD, Medical Oncology Department, MD Anderson Cancer Center, C/Arturo Soria 270, 28033 Madrid, Spain. E-mail: agonzalezm{at}seom.org.

Citation

González-Martín A, Pautier P, Mahner S, et al
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial

Publication history

  • Received December 8, 2015
  • Accepted January 26, 2016
  • First published June 1, 2016.
Online issue publication 
June 01, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.